Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-14 Sale | 2024-03-18 6:00 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 48,871 | $5.39 | $263,415 | 732,919 (Direct) | View |
| 2023-11-30 Sale | 2023-12-01 7:42 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 965 | $1.97 | $1,901 | 381,790 (Direct) | View |
| 2023-09-27 Sale | 2023-09-29 8:02 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 9,720 | $2.7 | $26,244 | 382,755 (Direct) | View |
| 2023-01-11 Sale | 2023-01-13 4:30 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 4,495 | $0.91 | $4,090 | 392,475 (Direct) | View |
| 2021-05-26 Sale | 2021-05-28 7:12 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 2,894 | $18.35 | $53,105 | 33,570 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-21 Option Award | 2023-12-22 8:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 400,000 | $0 | 781,790 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-13 4:30 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 300,000 | $0 | 392,475 (Direct) | View |
| 2022-08-02 Disposition | 2022-08-04 8:35 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 458,408 | $0 | 229,204 (Direct) | View |
| 2022-04-13 Option Award | 2022-04-15 7:07 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-11 6:44 pm | N/A 2032-01-07 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 52,800 | $0 | 118,070 (Direct) | View |
| 2021-12-14 Option Award(A) | 2022-01-11 6:41 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 31,700 | $0 | 65,270 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 8:29 pm | N/A 2031-12-14 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 52,800 | $0 | 86,370 (Direct) | View |
| 2020-12-10 Option Award | 2020-12-14 9:42 pm | N/A 2030-12-10 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 81,700 | $0 | 81,700 (Direct) | View |
| 2020-03-09 Option Award | 2020-03-11 5:59 pm | N/A 2030-03-09 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 215,889 | $0 | 215,889 (Direct) | View |
Ownership | 2020-03-05 5:40 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |